Injective (INJ) is currently priced at $13.52, reflecting a 3.61% decline over the past 24 hours. The daily range has been relatively tight at 0.72%, with a high of $14.03 and a low of $13.31, indicating limited volatility in the short term.

Trading volume stands at approximately $95.13 million, equating to 7.20% of the market cap, suggesting moderate trading activity. The recent price action shows a slight downward trend, as evidenced by the 7-day price change of -1.30%, while the 14-day price change of +5.54% indicates a short-term recovery attempt.

The moving averages present a mixed picture; the 8 SMA and 13 SMA are slightly positive, while the 21 SMA indicates a minor uptick. Conversely, the 55 SMA and 144 SMA are both negative, reflecting bearish momentum in the longer term.

The RSI metrics suggest differing momentum; the 1-hour RSI is at 72, indicating overbought conditions in the very short term, while the 7-day RSI at 48 indicates a neutral stance. This divergence implies potential short-term retracement while maintaining a longer-term perspective.

Given the current price action, volume dynamics, and moving average trends, INJ appears to be experiencing short-term selling pressure after a brief rally. The resistance at higher levels near the 144 SMA suggests a cautious approach is warranted.

Considering these factors, the recommendation is to Hold Injective (INJ) for now. The current price action indicates potential short-term weakness, but the longer-term outlook remains supported by recent positive movements, warranting a wait-and-see approach.